Latest Court Proceedings News

Altair Minerals has successfully navigated the initial legal hearing against BHP over the contested use of its Olympic Domain Project area, setting the stage for a protracted dispute over exploration rights and project valuation.

Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.

Triton Minerals has settled a legal dispute with NQM Gold, paving the way for the completion of a $17 million graphite asset sale with structured payment terms and court proceedings adjourned.

Bathurst Resources reports a dip in FY25 earnings due to lower coal prices and operational challenges but pushes forward with key development projects Buller and Tenas, targeting production growth from FY29.

Mayne Pharma Group Limited reported a robust FY25 with a 5% revenue increase to A$408.1 million and a 105% surge in underlying EBITDA, driven by strong growth in Women’s Health and strategic acquisitions in Dermatology.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Altair Minerals is escalating its dispute with BHP over the undervaluation of its Olympic Domain Project by proceeding to South Australia’s Wardens Court. The junior explorer aims to defend the strategic and exploration value of its land amid ongoing negotiations with other majors.

London City Equities reported a $11.3 million capital gain primarily from trimming its Fiducian Group stake, reversing prior losses to post a $500,000 profit and declaring a 2.5 cent fully franked dividend including a special payout.

BPH Energy has responded to an ASX price query following unusual trading activity, confirming no undisclosed information exists and pointing to ongoing legal matters involving its investee Advent Energy as context.

Classic Minerals has completed a design study for a 250,000 tonnes per annum Carbon-in-Leach gold processing plant at Forrestania, appointing IPS Global as EPCM contractor and outlining a scalable growth strategy.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.

Classic Minerals Limited has secured strategic tenements adjoining its Forrestania Gold Project and appointed a drilling contractor under a novel drill-for-equity agreement, while navigating ongoing legal disputes and ASX suspension.